Brief: Immunicum To Acquire DCprime B.V.

Mendus AB (publ)

19/11/2020 07:46

Nov 19 (Reuters) - Immunicum AB (publ)  IMMUN.ST :
    * SAID ON WEDNESDAY IT HAS ENTERED INTO AN AGREEMENT WITH
VAN HERK
INVESTMENTS B.V. TO ACQUIRE ALL OF THE SHARES IN DCPRIME B.V.
    * PAYMENT IN THE TRANSACTION IS EFFECTUATED THROUGH AN ISSUE
IN
KIND OF 73,909,635 NEW SHARES IN IMMUNICUM REPRESENTING 44
PERCENT OF THE SHARES IN IMMUNICUM ON A FULLY DILUTED BASIS
    * MAIN OBJECTIVE OF COMBINATION IS TO ESTABLISH UNIFIED
COMPANY
BUILT ON DECADES OF COMBINED IMMUNO-ONCOLOGY AND CELL THERAPY
EXPERTISE IN THE FIELD OF ALLOGENEIC DENDRITIC CELL BIOLOGY
    * CLOSING OF THE TRANSACTION IS EXPECTED TO TAKE PLACE AT
THE END
OF DECEMBER 2020

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE6JJW5J
    
 Further company coverage:  IMMUN.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))